Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected pat...

por Pejša, Vlatko, Prka, Željko, Lucijanić, Marko, Mitrović, Zdravko, Piršić, Mario, Jakšić, Ozren, Ajduković, Radmila, Kušec, Rajko
Publicado 2017